Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer

Clinical trial NCT02157051 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02157051
Sponsor: University of Washington
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HER2 Negative Breast Carcinoma Recurrent Breast Carcinoma Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage III Breast Cancer

Start date: 2015-06-01
Primary completion: 2022-11-25
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.